Dr Reddy's to Set up Two SEZs
This article was originally published in PharmAsia News
Executive Summary
Business Standard (India) (05/21/07)
|
Business Standard (India) (05/21/07) Dr. Reddy's Laboratories is implementing a 2007 capital expenditure program of $100 million to create two new "special economic zones" in Hyderabad and Visakhapatnam, India, to boost manufacturing capacity. The Hyderabad development will focus on making active pharmaceutical ingredients, and the Visakhapatnam complex will focus on pharmaceutical products. Dr. Reddy's says it plans to launch 10 new pharmaceutical products during this current fiscal year. During the last fiscal year, the company scored significant revenue from gaining 180-day market exclusivity approval for simvastatin, finasteride, and ondansetron. Dr. Reddy's plans to push for new exclusivities as part of their revenue strategy. Today they have 69 pending applications at the U.S. FDA for drug products. (Click here for more ) |